Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose

Rinaldo Bellomo, Johan Mårtensson, Serigne Lo, Kirsi-Maija Kaukonen, Alan Cass, Martin Gallagher

Research output: Contribution to journalArticleResearchpeer-review

17 Citations (Scopus)

Abstract

Aims: The study aims to describe the use of dialysis catheters in critically ill patients treated with continuous renal replacement therapy (CRRT) and to study the impact of femoral versus non-femoral access on CRRT dose. Methods: Statistical analysis and predictive modelling of data from the Randomized Evaluation of Normal vs. Augmented Level renal replacement therapy trial. Results: The femoral vein was the first access site in 937 (67%) of 1,399 patients. These patients had higher Acute Physiology and Chronic Health Evaluation and Sequential Organ Failure Assessment scores (p = 0.009) and lower pH (p < 0.001) but similar mortality to patients with non-femoral access (44 vs. 45%; p = 0.63). Lower body weight was independently associated with femoral access placement (OR 0.97, 95% CI 0.96-0.98). Femoral access was associated with a 1.03% lower CRRT dose (p = 0.05), but a 4.20% higher dose was achieved with 13.5 Fr catheters (p = 0.03). Conclusions: Femoral access was preferred in lighter and sicker patients. Catheter gauge had greater impact than catheter site in CRRT dose delivery. Video Journal Club "Cappuccino with Claudio Ronco" at http://www.karger.com/?doi=439581.

Original languageEnglish
Pages (from-to)11-17
Number of pages7
JournalBlood Purification
Volume41
Issue number1-3
DOIs
Publication statusPublished - 1 Mar 2016

Keywords

  • Catheters
  • Continuous renal replacement therapy
  • Dialysis
  • Femoral vein
  • Intensive care

Cite this

Bellomo, R., Mårtensson, J., Lo, S., Kaukonen, K-M., Cass, A., & Gallagher, M. (2016). Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose. Blood Purification, 41(1-3), 11-17. https://doi.org/10.1159/000439581
Bellomo, Rinaldo ; Mårtensson, Johan ; Lo, Serigne ; Kaukonen, Kirsi-Maija ; Cass, Alan ; Gallagher, Martin. / Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose. In: Blood Purification. 2016 ; Vol. 41, No. 1-3. pp. 11-17.
@article{b7dd4afdced343f1bc5b439a9914b7a2,
title = "Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose",
abstract = "Aims: The study aims to describe the use of dialysis catheters in critically ill patients treated with continuous renal replacement therapy (CRRT) and to study the impact of femoral versus non-femoral access on CRRT dose. Methods: Statistical analysis and predictive modelling of data from the Randomized Evaluation of Normal vs. Augmented Level renal replacement therapy trial. Results: The femoral vein was the first access site in 937 (67{\%}) of 1,399 patients. These patients had higher Acute Physiology and Chronic Health Evaluation and Sequential Organ Failure Assessment scores (p = 0.009) and lower pH (p < 0.001) but similar mortality to patients with non-femoral access (44 vs. 45{\%}; p = 0.63). Lower body weight was independently associated with femoral access placement (OR 0.97, 95{\%} CI 0.96-0.98). Femoral access was associated with a 1.03{\%} lower CRRT dose (p = 0.05), but a 4.20{\%} higher dose was achieved with 13.5 Fr catheters (p = 0.03). Conclusions: Femoral access was preferred in lighter and sicker patients. Catheter gauge had greater impact than catheter site in CRRT dose delivery. Video Journal Club {"}Cappuccino with Claudio Ronco{"} at http://www.karger.com/?doi=439581.",
keywords = "Catheters, Continuous renal replacement therapy, Dialysis, Femoral vein, Intensive care",
author = "Rinaldo Bellomo and Johan M{\aa}rtensson and Serigne Lo and Kirsi-Maija Kaukonen and Alan Cass and Martin Gallagher",
year = "2016",
month = "3",
day = "1",
doi = "10.1159/000439581",
language = "English",
volume = "41",
pages = "11--17",
journal = "Blood Purification",
issn = "0253-5068",
publisher = "Karger",
number = "1-3",

}

Bellomo, R, Mårtensson, J, Lo, S, Kaukonen, K-M, Cass, A & Gallagher, M 2016, 'Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose', Blood Purification, vol. 41, no. 1-3, pp. 11-17. https://doi.org/10.1159/000439581

Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose. / Bellomo, Rinaldo; Mårtensson, Johan; Lo, Serigne; Kaukonen, Kirsi-Maija; Cass, Alan; Gallagher, Martin.

In: Blood Purification, Vol. 41, No. 1-3, 01.03.2016, p. 11-17.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose

AU - Bellomo, Rinaldo

AU - Mårtensson, Johan

AU - Lo, Serigne

AU - Kaukonen, Kirsi-Maija

AU - Cass, Alan

AU - Gallagher, Martin

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Aims: The study aims to describe the use of dialysis catheters in critically ill patients treated with continuous renal replacement therapy (CRRT) and to study the impact of femoral versus non-femoral access on CRRT dose. Methods: Statistical analysis and predictive modelling of data from the Randomized Evaluation of Normal vs. Augmented Level renal replacement therapy trial. Results: The femoral vein was the first access site in 937 (67%) of 1,399 patients. These patients had higher Acute Physiology and Chronic Health Evaluation and Sequential Organ Failure Assessment scores (p = 0.009) and lower pH (p < 0.001) but similar mortality to patients with non-femoral access (44 vs. 45%; p = 0.63). Lower body weight was independently associated with femoral access placement (OR 0.97, 95% CI 0.96-0.98). Femoral access was associated with a 1.03% lower CRRT dose (p = 0.05), but a 4.20% higher dose was achieved with 13.5 Fr catheters (p = 0.03). Conclusions: Femoral access was preferred in lighter and sicker patients. Catheter gauge had greater impact than catheter site in CRRT dose delivery. Video Journal Club "Cappuccino with Claudio Ronco" at http://www.karger.com/?doi=439581.

AB - Aims: The study aims to describe the use of dialysis catheters in critically ill patients treated with continuous renal replacement therapy (CRRT) and to study the impact of femoral versus non-femoral access on CRRT dose. Methods: Statistical analysis and predictive modelling of data from the Randomized Evaluation of Normal vs. Augmented Level renal replacement therapy trial. Results: The femoral vein was the first access site in 937 (67%) of 1,399 patients. These patients had higher Acute Physiology and Chronic Health Evaluation and Sequential Organ Failure Assessment scores (p = 0.009) and lower pH (p < 0.001) but similar mortality to patients with non-femoral access (44 vs. 45%; p = 0.63). Lower body weight was independently associated with femoral access placement (OR 0.97, 95% CI 0.96-0.98). Femoral access was associated with a 1.03% lower CRRT dose (p = 0.05), but a 4.20% higher dose was achieved with 13.5 Fr catheters (p = 0.03). Conclusions: Femoral access was preferred in lighter and sicker patients. Catheter gauge had greater impact than catheter site in CRRT dose delivery. Video Journal Club "Cappuccino with Claudio Ronco" at http://www.karger.com/?doi=439581.

KW - Catheters

KW - Continuous renal replacement therapy

KW - Dialysis

KW - Femoral vein

KW - Intensive care

UR - http://www.scopus.com/inward/record.url?scp=84945122056&partnerID=8YFLogxK

U2 - 10.1159/000439581

DO - 10.1159/000439581

M3 - Article

AN - SCOPUS:84945122056

VL - 41

SP - 11

EP - 17

JO - Blood Purification

JF - Blood Purification

SN - 0253-5068

IS - 1-3

ER -

Bellomo R, Mårtensson J, Lo S, Kaukonen K-M, Cass A, Gallagher M. Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose. Blood Purification. 2016 Mar 1;41(1-3):11-17. https://doi.org/10.1159/000439581